InvestorsHub Logo

couldbebetter

05/03/19 6:15 AM

#189858 RE: Sabre2870 #189856

For "whatever" reason management is not telling us exactly what is
going on with Europe. I wonder if somehow a potential partner (or
acquirer) may be involved in helping AMRN in some way with the filing.
Europe will be (potentially) a very lucrative market without competition
so for many "potential" partners it may be a must have. Obviously,
from the Dow Jones interview with JT it sounds as if Novartis may be
very interested, perhaps even to the point of acquiring AMRN. Europe
was under consideration for partnering a long time ago but management
held off. Europe will require either a distribution agreement or an
outright buyout. The lack of the former keeps the latter alive.